Salvatore Salomone Selected Research

Salvatore Salomone Research Topics

Disease

12	Inflammation (Inflammations) 10/2019 - 05/2008
9	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2020 - 07/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2012
6	Schizophrenia (Dementia Praecox) 01/2021 - 01/2017
4	Cognitive Dysfunction 01/2021 - 01/2017
4	Neoplasms (Cancer) 01/2018 - 03/2013
4	Macular Degeneration (Age-Related Maculopathy) 09/2017 - 01/2015
4	Type 2 Diabetes Mellitus (MODY) 02/2013 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2013
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021 - 01/2019
3	Memory Disorders (Memory Loss) 01/2021 - 04/2016
3	Glaucoma 01/2015 - 02/2013
3	Stroke (Strokes) 12/2008 - 05/2007
3	Ulcer 08/2003 - 06/2002
2	COVID-19 01/2021 - 01/2020
2	Hyperglycemia 10/2020 - 10/2019
2	Neurobehavioral Manifestations 01/2020 - 01/2016
2	Drug-Related Side Effects and Adverse Reactions 01/2018 - 11/2012
2	Retinal Diseases 01/2018 - 01/2015
2	Hypoxia (Hypoxemia) 01/2016 - 05/2007
2	Ocular Hypertension (Glaucoma, Suspect) 11/2013 - 02/2013
2	Migraine Disorders (Migraine) 10/2009 - 01/2004
2	Brain Ischemia (Cerebral Ischemia) 05/2008 - 05/2007
2	Stomach Ulcer (Gastric Ulcer) 08/2003 - 01/2003
1	Multiple Sclerosis 01/2022
1	Wounds and Injuries (Trauma) 05/2021
1	Paralysis (Palsy) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Retinal Detachment (Retinal Detachments) 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Proliferative Vitreoretinopathy 01/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Macular Edema 10/2019
1	Fibrosis (Cirrhosis) 12/2018
1	Myasthenia Gravis 02/2018

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
10	Retinaldehyde (Retinal)IBA 10/2020 - 07/2012
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 12/2013
5	Amyloid (Amyloid Fibrils)IBA 01/2021 - 02/2014
5	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 12/2013
4	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2015
4	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 11/2013
4	Antipsychotic Agents (Antipsychotics)IBA 11/2020 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2014
3	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2016
3	CannabidiolIBA 01/2021 - 01/2019
3	ThiazolidinedionesIBA 02/2013 - 01/2011
3	AdrenomedullinIBA 08/2003 - 06/2002
2	AntioxidantsIBA 01/2021 - 01/2018
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2021 - 01/2019
2	VortioxetineIBA 01/2021 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2020
2	CannabinoidsIBA 01/2021 - 01/2019
2	Phospholipases A2 (Phospholipase A2)IBA 10/2020 - 12/2013
2	Dopamine D3 ReceptorsIBA 01/2020 - 01/2017
2	Methylazoxymethanol AcetateIBA 01/2020 - 01/2019
2	afliberceptIBA 10/2019 - 01/2015
2	Purinergic P2X7 ReceptorsIBA 10/2019 - 01/2017
2	SteroidsIBA 12/2018 - 11/2013
2	Biological ProductsIBA 12/2018 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 04/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017 - 04/2015
2	Buspirone (Buspar)FDA LinkGeneric 01/2017 - 07/2014
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2015 - 07/2014
2	HomocysteineIBA 01/2015 - 01/2014
2	LigandsIBA 11/2013 - 06/2012
2	rho-Associated KinasesIBA 12/2008 - 05/2007
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2008 - 05/2007
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2021
1	Paroxetine (Paxil)FDA LinkGeneric 05/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	pimavanserinIBA 01/2020
1	DysbindinIBA 01/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Retinal Pigments (Pigments, Visual)IBA 01/2020
1	VaccinesIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	brexpiprazoleIBA 01/2020
1	Antimitotic AgentsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	AM 251 (AM251)IBA 01/2019
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	SynaptophysinIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Neostigmine (Neostigmine Bromide)IBA 02/2018

Therapy/Procedure

5	Therapeutics 01/2018 - 05/2003
4	Drug Therapy (Chemotherapy) 01/2019 - 05/2012
2	Precision Medicine 11/2020 - 01/2020
1	Conduction Anesthesia (Regional Anesthesia) 01/2021
1	Drug Prescriptions 01/2018